James R. Henry

2.6k citations

31 papers · 1.4k indexed · h-index 16

Organic Chemistry top 2%
- Oxidative Organic Chemistry Reactions 3
- Synthesis and biological activity 2
- Catalytic Cross-Coupling Reactions 2
Molecular Biology
- Melanoma and MAPK Pathways 9
- Fibroblast Growth Factor Research 2
Oncology
Biotechnology top 10%
Cancer Research
Pathology and Forensic Medicine
- Cancer Mechanisms and Therapy 3
Renewable Energy, Sustainability and the Environment
- Electrocatalysts for Energy Conversion 3
Electrical and Electronic Engineering
- Electrodeposition and Electroless Coatings 3

Co-authors: Steven M. Weinreb John H. Dodd Druie Cavender Kenneth C. Rupert John J. Siekierka Scott Wadsworth Gilbert C. Olini Georgianna Harris
Cited by: Organic Chemistry Molecular Biology Oncology
Journals: Journal of Biological Chemistry (1 paper)Cancer Research (2 papers)Clinical Cancer Research (1 paper)
Partner nations: United States Czechia Spain

In The Last Decade

James R. Henry

30 papers receiving 1.3k citations

Peers

Countries citing papers authored by James R. Henry

Since Specialization

Citations

This map shows the geographic impact of James R. Henry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James R. Henry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James R. Henry more than expected).

Fields of papers citing papers by James R. Henry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James R. Henry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James R. Henry. The network helps show where James R. Henry may publish in the future.

Co-authorship network

The 25 scholars most cited alongside James R. Henry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with James R. Henry Line = papers co-authored together James R. Henry links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Abstract 5245: Identification and characterization of the IDO1 inhibitor LY3381916 Cancer Research ·Frank C. Dorsey,Karim A. Benhadji,Lillian Sams,Debra A. Young,John F. Schindler,Karen Huss,Alexander Nikolayev,Carmine Carpenito,David K. Clawson,Bonita D. Jones,Andrew L. Faber,James E. Thomas,Steven A. Haney,Gaiying Zhao,William T. McMillen,Tod Smeal,Daniel J. Sall,Michael Kalos,Sandaruwan Geeganage,James R. Henry	2018	13
2	Mouse PDX Trial Suggests Synergy of Concurrent Inhibition of RAF and EGFR in Colorectal Cancer with BRAF or KRAS Mutations Clinical Cancer Research ·Yung-Mae Yao,Gregory P. Donoho,Philip W. Iversen,Youyan Zhang,Robert D. Van Horn,Amélie Forest,Ruslan D. Novosiadly,Yue Webster,Philip J. Ebert,Steven M. Bray,Jason C. Ting,Amit Aggarwal,James R. Henry,Ramón V. Tiu,Gregory D. Plowman,Sheng‐Bin Peng	2017	39
3	Oncogenic BRAF Deletions That Function as Homodimers and Are Sensitive to Inhibition by RAF Dimer Inhibitor LY3009120 Cancer Discovery ·Shih-Hsun Chen,Youyan Zhang,Robert D. Van Horn,Tinggui Yin,Sean G. Buchanan,Vipin Yadav,Igor Mochalkin,Swee Seong Wong,Yong Yue,Lysiane Huber,Ilaria Conti,James R. Henry,James J. Starling,Gregory D. Plowman,Sheng-Bin Peng	2016	117
4	Reactivation of Mitogen-activated Protein Kinase (MAPK) Pathway by FGF Receptor 3 (FGFR3)/Ras Mediates Resistance to Vemurafenib in Human B-RAF V600E Mutant Melanoma Journal of Biological Chemistry ·Vipin Yadav,Xiaoyi Zhang,Jiangang Liu,Shawn T. Estrem,Shuyu Li,Xueqian Gong,Sean G. Buchanan,James R. Henry,James J. Starling,Sheng-Bin Peng	2012	160
5	Discovery of LY2457546: a multi-targeted anti-angiogenic kinase inhibitor with a novel spectrum of activity and exquisite potency in the acute myelogenous leukemia-Flt-3-internal tandem duplication mutant human tumor xenograft model Investigational New Drugs ·Timothy P. Burkholder,Joshua R. Clayton,Mark E. Rempala,James R. Henry,John M. Knobeloch,David Mendel,Johnathan McLean,Yan Hao,David A. Barda,Eileen L. Considine,Mark Uhlik,Yuefeng Chen,Liandong Ma,Laura J. Bloem,Jacqueline K. Akunda,Denis McCann,Manuel Sánchez-Félix,David K. Clawson,Michael Lahn,James J. Starling	2011	16
6	A Novel, Selective Inhibitor of Fibroblast Growth Factor Receptors That Shows a Potent Broad Spectrum of Antitumor Activity in Several Tumor Xenograft Models Molecular Cancer Therapeutics ·Genshi Zhao,Weiying Li,Daohong Chen,James R. Henry,Hongyu Li,Zhaogen Chen,Mohammad Zia‐Ebrahimi,Laura J. Bloem,Yan Zhai,Karen Huss,Sheng‐Bin Peng,Denis McCann	2011	165
7	Synthesis and evaluation of aminomethyl dihydrocinnamates as a new class of PPAR ligands Bioorganic & Medicinal Chemistry Letters ·Alan M. Warshawsky,Charles A. Alt,Joseph T. Brozinick,Allen R. Harkness,Eric D. Hawkins,James R. Henry,Donald P. Matthews,Anne Reifel Miller,Elizabeth A. Misener,Chahrzad Montrose‐Rafizadeh,Gary A. Rhodes,Quanrong Shen,Jennifer A. Vance,Uko E. Udodong,Minmin Wang,Tony Y. Zhang,Richard W. Zink	2006	3
8	Tetrahydroisoquinoline PPARγ agonists: Design of novel, highly selective non-TZD antihyperglycemic agents Bioorganic & Medicinal Chemistry Letters ·James R. Henry,Yihong Li,Alan M. Warshawsky,Joseph T. Brozinick,Eric D. Hawkins,Elizabeth A. Misener,Daniel A. Briere,Chahrzad Montrose‐Rafizadeh,Richard W. Zink,Nathan Yumibe,Rose T. Ajamie,Brad Wilken,Viswanath Devanarayan	2006	1
9	Imidazopyrimidines, potent inhibitors of p38 MAP kinase Bioorganic & Medicinal Chemistry Letters ·Kenneth C. Rupert,James R. Henry,John H. Dodd,Scott Wadsworth,Druie Cavender,Gilbert C. Olini,Bohumila Fahmy,John J. Siekierka	2003	233
10	Electroless (autocatalytic) plating Metal Finishing ·James R. Henry	2002	9
11	Electroless (autocatalytic) plating Metal Finishing ·James R. Henry	1999	9
12	Electroless (autocatalytic) plating Metal Finishing ·James R. Henry	1999	7
13	p38 Mitogen-activated protein kinase as a target for drug discovery Drugs of the Future ·James R. Henry,Druie Cavender,Sarah Wadsworth	1999	10
14	The development of novel and selective p56lck tyrosine kinase inhibitors Bioorganic & Medicinal Chemistry Letters ·James L. Bullington,Julie C. Cameron,Janet E. Davis,John H. Dodd,Crafford A. Harris,James R. Henry,J. Lee Pellegrino-Gensey,Kenneth C. Rupert,John J. Siekierka	1998	7
15	Potent inhibitors of the MAP kinase p38 Bioorganic & Medicinal Chemistry Letters ·James R. Henry,Kenneth C. Rupert,John H. Dodd,Ignatius J. Turchi,Scott Wadsworth,Druie Cavender,Peter Schäfer,John J. Siekierka	1998	34
16	Further Studies on Total Synthesis of Sarain A. Efforts Toward Annulation of the Macrocyclic Rings The Journal of Organic Chemistry ·Osamu Irie,Kiyohiro Samizu,James R. Henry,Steven M. Weinreb	1998	40
17	Enantioselective total synthesis of didesepoxyrhizoxin Tetrahedron Letters ·Andrew S. Kende,Benjamin E. Blass,James R. Henry	1995	25
18	A convenient, mild method for oxidative cleavage of alkenes with Jones reagent/osmium tetraoxide The Journal of Organic Chemistry ·James R. Henry,Steven M. Weinreb	1993	47
19	Development of a strategy for synthesis of the unusual marine alkaloid sarain A The Journal of Organic Chemistry ·Joseph Sisko,James R. Henry,Steven M. Weinreb	1993	66
20	High-pressure induced 1,3-dipolar cycloadditions of azides with electron-deficient olefins The Journal of Organic Chemistry ·Glen T. Anderson,James R. Henry,Steven M. Weinreb	1991	43

About James R. Henry

James R. Henry is a scholar working on Biological Psychiatry, Biotechnology and Organic Chemistry, having authored 31 papers that have together received 1.4k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (9 papers), Cancer Mechanisms and Therapy (3 papers), Electrocatalysts for Energy Conversion (3 papers), Electrodeposition and Electroless Coatings (3 papers), Oxidative Organic Chemistry Reactions (3 papers), Synthesis and biological activity (2 papers), Fibroblast Growth Factor Research (2 papers) and Catalytic Cross-Coupling Reactions (2 papers). The work is most often cited by research in Organic Chemistry (731 citations), Molecular Biology (655 citations) and Oncology (211 citations). James R. Henry has collaborated with scholars based in United States, Czechia and Spain. Frequent co-authors include Steven M. Weinreb, John H. Dodd, Druie Cavender, Kenneth C. Rupert, John J. Siekierka, Scott Wadsworth, Gilbert C. Olini, Georgianna Harris, Matthias C. McIntosh and Lawrence R. Marcin. Their work appears in journals such as Journal of Biological Chemistry, Cancer Research and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact